tiprankstipranks
XBiotech (XBIT)
NASDAQ:XBIT
US Market

XBiotech (XBIT) Financial Statements

344 Followers

XBiotech Financial Overview

XBiotech's market cap is currently $67.99M. The company's EPS TTM is $-1.32; its P/E ratio is -1.69; XBiotech is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 4.01M$ 18.39M
Gross Profit$ -1.69M$ 0.00$ 0.00$ 3.36M$ 12.57M
Operating Income$ -55.69M$ -42.47M$ -37.51M$ -34.49M$ -25.08M
EBITDA$ -43.53M$ -36.01M$ -22.57M$ -30.97M$ -22.81M
Net Income$ -45.54M$ -38.53M$ -24.56M$ -32.90M$ -17.41M
Balance Sheet
Cash & Short-Term Investments$ 125.55M$ 172.68M$ 200.02M$ 217.48M$ 236.98M
Total Assets$ 150.08M$ 199.09M$ 226.62M$ 246.10M$ 275.18M
Total Debt$ 0.00$ 10.25M$ 0.00$ 0.00$ 0.00
Net Debt$ -125.55M$ -162.43M$ -200.02M$ -157.31M$ -236.98M
Total Liabilities$ 9.73M$ 16.82M$ 7.77M$ 5.70M$ 5.79M
Stockholders' Equity$ 140.35M$ 182.27M$ 218.85M$ 240.40M$ 269.38M
Cash Flow
Free Cash Flow$ -40.21M$ -32.27M$ -19.09M$ -15.41M$ 65.92M
Operating Cash Flow$ -39.92M$ -30.96M$ -18.73M$ -14.82M$ 69.44M
Investing Cash Flow$ -289.00K$ -1.30M$ 61.50M$ -63.89M$ -3.52M
Financing Cash Flow$ -10.25M$ 10.45M$ -9.00K$ 0.00$ -67.01M
Currency in USD

XBiotech Earnings and Revenue History

XBiotech Debt to Assets

XBiotech Cash Flow

XBiotech Forecast EPS vs Actual EPS